1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Brucellosis Global Clinical Trials Review, H2, 2015

Brucellosis Global Clinical Trials Review, H2, 2015

  • December 2015
  • -
  • Global Data
  • -
  • 29 pages

Brucellosis Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Brucellosis Global Clinical Trials Review, H2, 2015" provides an overview of Brucellosis clinical trials scenario. This report provides top line data relating to the clinical trials on Brucellosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Brucellosis Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Figures 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Europe 8
Top Countries Contributing to Clinical Trials in Middle East and Africa 9
Clinical Trials by E7 Countries: Proportion of Brucellosis to Infectious Disease Clinical Trials 10
Clinical Trials by Phase 11
In Progress Trials by Phase 12
Clinical Trials by Trial Status 13
Clinical Trials by End Point Status 14
Subjects Recruited Over a Period of Time 15
Prominent Drugs 16
Clinical Trial Profile Snapshots 17
Appendix 26
Abbreviations 26
Definitions 26
Research Methodology 27
Secondary Research 27
About GlobalData 28
Contact Us 28
Disclaimer 28
Source 29

List of Figures
Brucellosis Therapeutics, Global, Clinical Trials by Region, 2015* 5
Brucellosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Brucellosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7
Brucellosis Therapeutics Clinical Trials, Europe, Top Countries, 2015* 8
Brucellosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 9
Proportion of Brucellosis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 10
Brucellosis Therapeutics, Global, Clinical Trials by Phase, 2015* 11
Brucellosis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 12
Brucellosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 13
Brucellosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 14
Brucellosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 15
Brucellosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 16

List of Figures
Brucellosis Therapeutics, Global, Clinical Trials by Region (%), 2015* 5
Brucellosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 6
Brucellosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 7
Brucellosis Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 8
Proportion of Brucellosis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 10
Brucellosis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 11
Brucellosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 12
Brucellosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 13
Brucellosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 14
Brucellosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 15
Brucellosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 16
GlobalData Methodology 27

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.